Across TCGA pan-cancer cohorts, OR5B1P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR5B1P’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where OR5B1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5B1P is over-expressed in tumor.
LUAD are the cancer types where OR5B1P tumor–normal differential expression is most reproducible.